secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001730463-23-000125
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus appoints Elisabeth Leiderman to board; Kapil Dhingra resigns
--------------------------------------------------------------------

- Kapil Dhingra resigned from Board effective Dec 31, 2023; not due to any disagreement with company.
- Elisabeth Leiderman appointed as Class II director effective Dec 20, 2023; will serve on Audit Committee.
- Leiderman receives £52,500 annual retainer, £6,500 audit committee retainer, and option to purchase 80,000 ADSs at $5.50.
- Leiderman most recently CFO/CBO of Atsena Therapeutics; also serves on bluebird bio board.
- Press release also notes BLA submission for obe-cel in r/r adult B-ALL to FDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046323000125/0001730463-23-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046323000125/autl-20231219.htm
  HTML page:      https://secwatch.observer/filing/0001730463-23-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer